 | • レポートコード：MRC2303F0098 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、220ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：医薬品 |
| Single User（1名利用、印刷可） | ￥742,350 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,492,350 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社の本調査資料は、2021年に5,502.11百万ドルであった世界のニキビ治療薬市場規模が、2022年に5,921.91百万ドルになり、2027年まで年平均7.80%で成長して8,637.90百万ドルに到達すると予想しています。本調査資料では、ニキビ治療薬の世界市場について調査し、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、ニキビタイプ別（コメドナル、嚢胞性、炎症性、術後＆創傷）分析、薬物クラス別（抗生物質、配合剤、ホルモン剤、レチノイド）分析、薬物タイプ別（一般用医薬品、医療用医薬品）分析、投与経路別（注射、経口、局所）分析、地域別（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）分析、競争状況、企業情報などを以下の構成でまとめております。さらに、市場参入企業として、AbbVie Inc.、Almirall, S.A.、AndroScience Corporation、Anterios Inc、Bausch Health Companies Inc.、Bayer AG、BioPharmX, Inc、Cipher Pharmaceuticals Inc.、Daiichi Sankyo Company, Ltd、F. Hoffmann-La Roche AG、Foamix Pharmaceuticals Ltd.、Galderma S.A.、Guthy-Renker LLC、Johnson & Johnson Services, Inc、Mayne Pharma Group Limited、Medicis Pharmaceutical Corporation、Mylan N.V、Oculus Innovative Sciencesなどの情報が含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界のニキビ治療薬市場規模：ニキビタイプ別 - コメドナルニキビの市場規模 - 嚢胞性ニキビの市場規模 - 炎症性ニキビの市場規模 - 術後＆創傷の市場規模 ・世界のニキビ治療薬市場規模：薬物クラス別 - 抗生物質の市場規模 - 配合剤の市場規模 - ホルモン剤の市場規模 - レチノイドの市場規模 ・世界のニキビ治療薬市場規模：薬物タイプ別 - 一般用医薬品の市場規模 - 医療用医薬品の市場規模 ・世界のニキビ治療薬市場規模：投与経路別 - 注射の市場規模 - 経口の市場規模 - 局所の市場規模 ・世界のニキビ治療薬市場規模：地域別 - 南北アメリカのニキビ治療薬市場規模 アメリカのニキビ治療薬市場規模 カナダのニキビ治療薬市場規模 ブラジルのニキビ治療薬市場規模 ... - アジア太平洋のニキビ治療薬市場規模 日本のニキビ治療薬市場規模 中国のニキビ治療薬市場規模 インドのニキビ治療薬市場規模 韓国のニキビ治療薬市場規模 台湾のニキビ治療薬市場規模 ... -ヨーロッパ/中東/アフリカのニキビ治療薬市場規模 イギリスのニキビ治療薬市場規模 ドイツのニキビ治療薬市場規模 フランスのニキビ治療薬市場規模 ロシアのニキビ治療薬市場規模 ... -その他地域のニキビ治療薬市場規模 ・競争状況 ・企業情報 |
The Global Acne Drugs Market size was estimated at USD 5,502.11 million in 2021 and expected to reach USD 5,921.91 million in 2022, and is projected to grow at a CAGR 7.80% to reach USD 8,637.90 million by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Acne Drugs to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Acne Type, the market was studied across Comedonal, Cystic, Inflammatory, and Postsurgical/Wound.
Based on Drug Class, the market was studied across Antibiotics, Combination Drugs, Hormonal Agents, and Retinoids.
Based on Drug Type, the market was studied across OTC Drugs and Prescription Drugs.
Based on Route of Administration, the market was studied across Injectable, Oral, and Topical.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Acne Drugs market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Acne Drugs Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Acne Drugs Market, including AbbVie Inc., Almirall, S.A., AndroScience Corporation, Anterios Inc, Bausch Health Companies Inc., Bayer AG, BioPharmX, Inc, Cipher Pharmaceuticals Inc., Daiichi Sankyo Company, Ltd, F. Hoffmann-La Roche AG, Foamix Pharmaceuticals Ltd., Galderma S.A., Guthy-Renker LLC, Johnson & Johnson Services, Inc, Mayne Pharma Group Limited, Medicis Pharmaceutical Corporation, Mylan N.V, Oculus Innovative Sciences, Pfizer Inc., Ranbaxy Laboratories Limited, Skinvisible Pharmaceuticals, Stiefel Laboratories, Inc, Sun Pharmaceutical Industries Limited, Teva Pharmaceutical Industries Ltd, and Valeant Pharmaceutical International Inc.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Acne Drugs Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Acne Drugs Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Acne Drugs Market?
4. What is the competitive strategic window for opportunities in the Global Acne Drugs Market?
5. What are the technology trends and regulatory frameworks in the Global Acne Drugs Market?
6. What is the market share of the leading vendors in the Global Acne Drugs Market?
7. What modes and strategic moves are considered suitable for entering the Global Acne Drugs Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Extensive occurrence of skin-related diseases in individuals such as acne rosacea
5.1.1.2. Burgeoning awareness among people about the perks of using skin care products
5.1.1.3. Increasing presence on potential online retail platforms coupled with available disposable income
5.1.2. Restraints
5.1.2.1. Availability of numerous alternatives for skin care drugs such as Ayurveda
5.1.3. Opportunities
5.1.3.1. Rising proclivity among consumers for cosmetics made of natural ingredients
5.1.3.2. Emerging demand for combination therapy
5.1.4. Challenges
5.1.4.1. Stringent regulations and complicated process in the approval of cosmetic drugs
5.2. Cumulative Impact of COVID-19
6. Acne Drugs Market, by Acne Type
6.1. Introduction
6.2. Comedonal
6.3. Cystic
6.4. Inflammatory
6.5. Postsurgical/Wound
7. Acne Drugs Market, by Drug Class
7.1. Introduction
7.2. Antibiotics
7.3. Combination Drugs
7.4. Hormonal Agents
7.5. Retinoids
8. Acne Drugs Market, by Drug Type
8.1. Introduction
8.2. OTC Drugs
8.3. Prescription Drugs
9. Acne Drugs Market, by Route of Administration
9.1. Introduction
9.2. Injectable
9.3. Oral
9.4. Topical
10. Americas Acne Drugs Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Acne Drugs Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Acne Drugs Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis, By Key Player
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion
14. Company Usability Profiles
14.1. AbbVie Inc.
14.1.1. Business Overview
14.1.2. Key Executives
14.1.3. Product & Services
14.2. Almirall, S.A.
14.2.1. Business Overview
14.2.2. Key Executives
14.2.3. Product & Services
14.3. AndroScience Corporation
14.3.1. Business Overview
14.3.2. Key Executives
14.3.3. Product & Services
14.4. Anterios Inc
14.4.1. Business Overview
14.4.2. Key Executives
14.4.3. Product & Services
14.5. Bausch Health Companies Inc.
14.5.1. Business Overview
14.5.2. Key Executives
14.5.3. Product & Services
14.6. Bayer AG
14.6.1. Business Overview
14.6.2. Key Executives
14.6.3. Product & Services
14.7. BioPharmX, Inc
14.7.1. Business Overview
14.7.2. Key Executives
14.7.3. Product & Services
14.8. Cipher Pharmaceuticals Inc.
14.8.1. Business Overview
14.8.2. Key Executives
14.8.3. Product & Services
14.9. Daiichi Sankyo Company, Ltd
14.9.1. Business Overview
14.9.2. Key Executives
14.9.3. Product & Services
14.10. F. Hoffmann-La Roche AG
14.10.1. Business Overview
14.10.2. Key Executives
14.10.3. Product & Services
14.11. Foamix Pharmaceuticals Ltd.
14.11.1. Business Overview
14.11.2. Key Executives
14.11.3. Product & Services
14.12. Galderma S.A.
14.12.1. Business Overview
14.12.2. Key Executives
14.12.3. Product & Services
14.13. Guthy-Renker LLC
14.13.1. Business Overview
14.13.2. Key Executives
14.13.3. Product & Services
14.14. Johnson & Johnson Services, Inc
14.14.1. Business Overview
14.14.2. Key Executives
14.14.3. Product & Services
14.15. Mayne Pharma Group Limited
14.15.1. Business Overview
14.15.2. Key Executives
14.15.3. Product & Services
14.16. Medicis Pharmaceutical Corporation
14.16.1. Business Overview
14.16.2. Key Executives
14.16.3. Product & Services
14.17. Mylan N.V
14.17.1. Business Overview
14.17.2. Key Executives
14.17.3. Product & Services
14.18. Oculus Innovative Sciences
14.18.1. Business Overview
14.18.2. Key Executives
14.18.3. Product & Services
14.19. Pfizer Inc.
14.19.1. Business Overview
14.19.2. Key Executives
14.19.3. Product & Services
14.20. Ranbaxy Laboratories Limited
14.20.1. Business Overview
14.20.2. Key Executives
14.20.3. Product & Services
14.21. Skinvisible Pharmaceuticals
14.21.1. Business Overview
14.21.2. Key Executives
14.21.3. Product & Services
14.22. Stiefel Laboratories, Inc
14.22.1. Business Overview
14.22.2. Key Executives
14.22.3. Product & Services
14.23. Sun Pharmaceutical Industries Limited
14.23.1. Business Overview
14.23.2. Key Executives
14.23.3. Product & Services
14.24. Teva Pharmaceutical Industries Ltd
14.24.1. Business Overview
14.24.2. Key Executives
14.24.3. Product & Services
14.25. Valeant Pharmaceutical International Inc
14.25.1. Business Overview
14.25.2. Key Executives
14.25.3. Product & Services
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing